Catheter Precision Inc (VTAK)
0.422
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.4146
-0.01
(-1.75%)
Pre-Market: 20:00
Catheter Precision Research and Development Expense (Quarterly): 0.063M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.063M |
| June 30, 2024 | 0.081M |
| March 31, 2024 | 0.037M |
| December 31, 2023 | -0.011M |
| September 30, 2023 | 0.112M |
| June 30, 2023 | 0.134M |
| March 31, 2023 | 0.24M |
| December 31, 2022 | 0.154M |
| September 30, 2022 | 0.727M |
| June 30, 2022 | 2.396M |
| March 31, 2022 | 3.115M |
| December 31, 2021 | 3.732M |
| September 30, 2021 | 2.942M |
| June 30, 2021 | 2.829M |
| March 31, 2021 | 2.75M |
| December 31, 2020 | 3.421M |
| Date | Value |
|---|---|
| September 30, 2020 | 2.312M |
| June 30, 2020 | 1.953M |
| March 31, 2020 | 1.295M |
| December 31, 2019 | 0.838M |
| September 30, 2019 | 1.182M |
| June 30, 2019 | 0.979M |
| March 31, 2019 | 1.531M |
| December 31, 2018 | 1.244M |
| September 30, 2018 | 0.224M |
| June 30, 2018 | 1.022M |
| March 31, 2018 | 0.286M |
| December 31, 2017 | 0.359M |
| September 30, 2017 | 0.413M |
| June 30, 2017 | 3.367M |
| March 31, 2017 | 0.379M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-0.011M
Minimum
Dec 2023
3.732M
Maximum
Dec 2021
1.456M
Average
1.066M
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics Inc | 2.858M |
| Perspective Therapeutics Inc | 12.03M |
| Retractable Technologies Inc | 0.1747M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.701M |